SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Icagen (ICGN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: scaram(o)uche6/26/2009 1:03:25 PM
   of 11
 
I don't want to clutter the "pain" thread with my ignorance, so I'll post here in ignored land.

ICGN has an exclusive sublicense to SCN9A? Exclusive means squat in the world of targets, but it does squarely indicate that Nav1.7 is one of the three Pfizer targets?

Anybody looked at the competitive stance here? Can anyone tell me why there is so little interest, why the company has been forced to seek "strategic alternatives"?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News